Evaluating the cost-benefit profile of CPI stem cell therapy requires a comprehensive examination. Supporters often emphasize the possibility for meaningful therapeutic benefits, principally in diseases where conventional medications have proven limited. However, crucially important to assess the substantial financial expenditure associated with CP